Colgate-Palmolive 4Q Sales Beat Estimates, Led by Latin America Division
By Denny Jacob
Colgate-Palmolive posted better-than-expected sales in the quarter, led by sales growth in its Latin America division.
The consumer-products company logged net income of $718 million, or 87 cents a share, for the fourth quarter ended Dec. 31, surging up from $5 million, or 1 cent a share, a year earlier. Adjusted earnings were also 87 cents a share, slightly above analysts' estimates of 85 cents.
Sales rose to $4.95 billion from $4.63 billion. Analysts polled by FactSet expected $4.89 billion.
The company's Latin America division, which accounted for nearly one-fourth of sales in the quarter, reported the biggest sales growth from a year earlier at 18%. Colgate-Palmolive noted that organic sales growth in the division was led by Argentina, Mexico, Brazil and Colombia.
For 2024, Colgate-Palmolive forecast sales growth in the range of 1% to 4% including a low single-digit negative impact from foreign exchange. It also said it expects organic sales growth to be within its long-term targeted range of 3% and 5%.
Colgate-Palmolive also expects to expand its gross profit margin and increase investment in advertising. It expects EPS growth in the double-digits, while on an adjusted basis, EPS growth is expected to be in the mid to high-single-digit range.
"Our results this year and our strong growth momentum, including improved organic volume performance, add to our confidence that we are well positioned to deliver consistent, compounded earnings per share growth in 2024 and beyond," said Chief Executive Noel Wallace.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
January 26, 2024 07:35 ET (12:35 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations